Kezar Life Sciences (KZR) Operating Margin (2021 - 2025)
Historic Operating Margin for Kezar Life Sciences (KZR) over the last 5 years, with Q2 2025 value amounting to 4834.11%.
- Kezar Life Sciences' Operating Margin fell 9970700.0% to 4834.11% in Q2 2025 from the same period last year, while for Jun 2025 it was 11670.11%, marking a year-over-year increase of 133995800.0%. This contributed to the annual value of 1591.77% for FY2023, which is N/A changed from last year.
- Per Kezar Life Sciences' latest filing, its Operating Margin stood at 4834.11% for Q2 2025, which was down 9970700.0% from 5080.4% recorded in Q1 2025.
- Kezar Life Sciences' Operating Margin's 5-year high stood at 8869.81% during Q4 2021, with a 5-year trough of 364.67% in Q3 2023.
- For the 5-year period, Kezar Life Sciences' Operating Margin averaged around 5601.58%, with its median value being 5964.43% (2022).
- In the last 5 years, Kezar Life Sciences' Operating Margin soared by 9557800bps in 2023 and then crashed by -11257100bps in 2024.
- Quarter analysis of 5 years shows Kezar Life Sciences' Operating Margin stood at 8869.81% in 2021, then plummeted by -32bps to 6001.1% in 2022, then crashed by -106bps to 364.67% in 2023, then soared by 1699bps to 5831.17% in 2024, then dropped by -17bps to 4834.11% in 2025.
- Its last three reported values are 4834.11% in Q2 2025, 5080.4% for Q1 2025, and 5831.17% during Q2 2024.